中国组织工程研究
中國組織工程研究
중국조직공정연구
Journal of Clinical Rehabilitative Tissue Engineering Research
2015年
14期
2192-2198
,共7页
刘雨亮%李军%何玉芹%卓锋%魏开斌
劉雨亮%李軍%何玉芹%卓鋒%魏開斌
류우량%리군%하옥근%탁봉%위개빈
干细胞%移植%静脉移植%人脐带间充质干细胞%局部移植%脊髓损伤
榦細胞%移植%靜脈移植%人臍帶間充質榦細胞%跼部移植%脊髓損傷
간세포%이식%정맥이식%인제대간충질간세포%국부이식%척수손상
Umbilical Cord%Mesenchymal Stem Cell Transplantation%Injections,Intravenous%Spinal Cord Injuries
背景:目前,来源于人脐带的间充质干细胞移植途径主要为局部移植,存在创伤大、出血多、并发症多等缺点,限制了其在临床上的广泛应用。目的:探讨静脉移植人脐带间充质干细胞治疗脊髓损伤的可行性。方法:80只Wistar大鼠成功制备脊髓打击模型,随机分为5组:空白对照组10只大鼠不进行任何移植;DMEM局部移植组15只、DMEM静脉移植组15只大鼠分别通过局部、静脉途径移植DMEM;细胞局部移植组20只、细胞静脉移植组20只大鼠分别通过局部、静脉途径移植人脐带间充质干细胞悬液。术后定期行BBB评分、组织学观察和免疫组化检测来评价脊髓修复情况。结果与结论:移植后1 d-2周各组间BBB评分差距小,差异无显著性意义;移植后4-12周,细胞局部移植组、细胞静脉移植组BBB评分明显高于其他3组,差异有显著性意义;细胞局部移植组、细胞静脉移植组间差异无显著性意义(P>0.05)。组织学观察显示,细胞局部移植组、细胞静脉移植组损伤局部形成的空洞及胶质瘢痕较其他3组都相对减少,而细胞静脉移植组和细胞局部移植组相近。以上结果表明静脉移植的人脐带间充质干细胞能迁移到脊髓损伤部位,对急性脊髓损伤产生修复作用,且效果与局部移植相似。该方式简单易行,避免二次损伤、感染等,为治疗脊髓损伤提供了一种新的细胞移植途径。
揹景:目前,來源于人臍帶的間充質榦細胞移植途徑主要為跼部移植,存在創傷大、齣血多、併髮癥多等缺點,限製瞭其在臨床上的廣汎應用。目的:探討靜脈移植人臍帶間充質榦細胞治療脊髓損傷的可行性。方法:80隻Wistar大鼠成功製備脊髓打擊模型,隨機分為5組:空白對照組10隻大鼠不進行任何移植;DMEM跼部移植組15隻、DMEM靜脈移植組15隻大鼠分彆通過跼部、靜脈途徑移植DMEM;細胞跼部移植組20隻、細胞靜脈移植組20隻大鼠分彆通過跼部、靜脈途徑移植人臍帶間充質榦細胞懸液。術後定期行BBB評分、組織學觀察和免疫組化檢測來評價脊髓脩複情況。結果與結論:移植後1 d-2週各組間BBB評分差距小,差異無顯著性意義;移植後4-12週,細胞跼部移植組、細胞靜脈移植組BBB評分明顯高于其他3組,差異有顯著性意義;細胞跼部移植組、細胞靜脈移植組間差異無顯著性意義(P>0.05)。組織學觀察顯示,細胞跼部移植組、細胞靜脈移植組損傷跼部形成的空洞及膠質瘢痕較其他3組都相對減少,而細胞靜脈移植組和細胞跼部移植組相近。以上結果錶明靜脈移植的人臍帶間充質榦細胞能遷移到脊髓損傷部位,對急性脊髓損傷產生脩複作用,且效果與跼部移植相似。該方式簡單易行,避免二次損傷、感染等,為治療脊髓損傷提供瞭一種新的細胞移植途徑。
배경:목전,래원우인제대적간충질간세포이식도경주요위국부이식,존재창상대、출혈다、병발증다등결점,한제료기재림상상적엄범응용。목적:탐토정맥이식인제대간충질간세포치료척수손상적가행성。방법:80지Wistar대서성공제비척수타격모형,수궤분위5조:공백대조조10지대서불진행임하이식;DMEM국부이식조15지、DMEM정맥이식조15지대서분별통과국부、정맥도경이식DMEM;세포국부이식조20지、세포정맥이식조20지대서분별통과국부、정맥도경이식인제대간충질간세포현액。술후정기행BBB평분、조직학관찰화면역조화검측래평개척수수복정황。결과여결론:이식후1 d-2주각조간BBB평분차거소,차이무현저성의의;이식후4-12주,세포국부이식조、세포정맥이식조BBB평분명현고우기타3조,차이유현저성의의;세포국부이식조、세포정맥이식조간차이무현저성의의(P>0.05)。조직학관찰현시,세포국부이식조、세포정맥이식조손상국부형성적공동급효질반흔교기타3조도상대감소,이세포정맥이식조화세포국부이식조상근。이상결과표명정맥이식적인제대간충질간세포능천이도척수손상부위,대급성척수손상산생수복작용,차효과여국부이식상사。해방식간단역행,피면이차손상、감염등,위치료척수손상제공료일충신적세포이식도경。
BACKGROUND:Currently, human umbilical cord derived-mesenchymal stem cel s are mainly for local transplantation, which has some shortcomings, such as large trauma, bleeding, complications, that limit its widespread application in clinical practice. OBJECTIVE:To investigate the feasibility of intravenous transplantation of human umbilical cord derived-mesenchymal stem cel s for repair of spinal cord injury. METHODS:Eighty Wistar rats with spinal cord hitting were divided into five groups:blank control group with no transplantation (n=10), DMEM local transplantation group (n=15), DMEM intravenous transplantation group (n=15), cel local transplantation group (n=20), cel intravenous transplantation group (n=20). The functional recovery of spinal cord injury was observed with Basso, Beattie and Bresnahan scores at regular time as wel as hematoxylin-eosin staining and immunohistochemistry staining. RESULTS AND CONCLUSION:During 1 day to 2 weeks after transplantation, there was no significant difference in the Basso, Beattie and Bresnahan scores between the five groups;within 4-12 weeks after transplantation, the Basso, Beattie and Bresnahan scores were significantly higher in the two cel transplantation groups than the other three groups, but there was no difference between these two cel transplantation groups (P>0.05). Histological observation showed that the number of voids and glial scars was less in the cel local transplantation group and cel intravenous transplantation group compared with the other three groups, and there was also no difference between the two cel transplantation groups. These results indicate that the intravenous transplantation of human umbilical cord derived-mesenchymal stem cel s is similar to the local transplantation in the repair of acute spinal cord injury, which is simple and avoids secondary injuries and various complications. It is recommended that this method provide a new approach for cel transplantation.